Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Estrogen receptor-beta expression in hereditary breast cancer.

Literature DB >> 12202682

Estrogen receptor-beta expression in hereditary breast cancer.

Maria Grazia Daidone, Silvia Veneroni, Vera Cappelletti, Paolo Radice, Marco A Pierotti, Mamoun Younes.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2002 PMID： 12202682 DOI： 10.1200/JCO.2002.99.116

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

5 in total

Review 1. ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches.

Authors: Jin-Qiang Chen; Jose Russo
Journal: Biochim Biophys Acta Date: 2009-06-13

2. Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.

Authors: Kelly-Anne Phillips; Roger L Milne; Matti A Rookus; Mary B Daly; Antonis C Antoniou; Susan Peock; Debra Frost; Douglas F Easton; Steve Ellis; Michael L Friedlander; Saundra S Buys; Nadine Andrieu; Catherine Noguès; Dominique Stoppa-Lyonnet; Valérie Bonadona; Pascal Pujol; Sue Anne McLachlan; Esther M John; Maartje J Hooning; Caroline Seynaeve; Rob A E M Tollenaar; David E Goldgar; Mary Beth Terry; Trinidad Caldes; Prue C Weideman; Irene L Andrulis; Christian F Singer; Kate Birch; Jacques Simard; Melissa C Southey; Håkan L Olsson; Anna Jakubowska; Edith Olah; Anne-Marie Gerdes; Lenka Foretova; John L Hopper
Journal: J Clin Oncol Date: 2013-08-05 Impact factor: 44.544

Estrogen receptor-beta expression in hereditary breast cancer.

Review 1. ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches.

2. Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.

3. Australian clinicians and chemoprevention for women at high familial risk for breast cancer.

4. Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.

5. Expression of estrogen receptor beta isoforms in pancreatic adenocarcinoma.